Alexander E. Drzezga
#153,753
Most Influential Person Now
Alexander E. Drzezga's AcademicInfluence.com Rankings
Alexander E. Drzezgaphilosophy Degrees
Philosophy
#8608
World Rank
#12020
Historical Rank
Logic
#5642
World Rank
#7055
Historical Rank
Alexander E. Drzezgabiology Degrees
Biology
#11687
World Rank
#15105
Historical Rank
Neuroscience
#1914
World Rank
#1970
Historical Rank
Download Badge
Philosophy Biology
Alexander E. Drzezga's Degrees
- PhD Neuroscience University of California, San Francisco
- Doctorate Medicine University of California, San Francisco
Why Is Alexander E. Drzezga Influential?
(Suggest an Edit or Addition)Alexander E. Drzezga's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. (2015) (1112)
- Selective changes of resting-state networks in individuals at risk for Alzheimer's disease (2007) (976)
- Multicenter Standardized 18F-FDG PET Diagnosis of Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementias (2008) (669)
- German Multicenter Study Investigating 177Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients (2017) (590)
- Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study (2003) (560)
- First Clinical Experience with Integrated Whole-Body PET/MR: Comparison to PET/CT in Patients with Oncologic Diagnoses (2012) (492)
- Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis. (2015) (476)
- Dominance for vestibular cortical function in the non-dominant hemisphere. (2003) (472)
- Neuronal dysfunction and disconnection of cortical hubs in non-demented subjects with elevated amyloid burden (2011) (326)
- Comparison of [18F]DCFPyL and [68Ga]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Relapsed Prostate Cancer (2015) (291)
- Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage. (2015) (285)
- Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET. (2005) (277)
- Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0 (2018) (271)
- Beta Amyloid in Alzheimer's Disease: Increased Deposition in Brain Is Reflected in Reduced Concentration in Cerebrospinal Fluid (2009) (267)
- Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease (2009) (254)
- PET/MRI for Neurologic Applications (2012) (235)
- Lasting cortical activation after repetitive TMS of the motor cortex (2000) (234)
- Central activation by histamine-induced itch: analogies to pain processing: a correlational analysis of O-15 H2O positron emission tomography studies (2001) (233)
- Cerebrospinal fluid tau and beta-amyloid 42 proteins identify Alzheimer disease in subjects with mild cognitive impairment. (2002) (231)
- Multimodal imaging in Alzheimer's disease: validity and usefulness for early detection (2015) (213)
- Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains. (2001) (210)
- Cerebral metabolic patterns at early stages of frontotemporal dementia and semantic dementia. A PET study (2004) (206)
- Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18F]fluoroethyl)-l-tyrosine PET (2015) (204)
- Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer’s disease (2008) (199)
- Decline of cerebral glucose metabolism in frontotemporal dementia: a longitudinal 18F-FDG-PET-study (2007) (193)
- A European multicentre PET study of fibrillar amyloid in Alzheimer’s disease (2012) (182)
- Vowel sound extraction in anterior superior temporal cortex (2006) (169)
- SPECT-CT (2008) (164)
- Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias (2020) (163)
- Inhalation of Nitric Oxide Prevents Ischemic Brain Damage in Experimental Stroke by Selective Dilatation of Collateral Arterioles (2012) (161)
- Multivariate and univariate neuroimaging biomarkers of Alzheimer's disease (2008) (160)
- A systematic review on the applications of resting-state fMRI in Parkinson's disease: Does dopamine replacement therapy play a role? (2015) (153)
- Linking Actions and Their Perceivable Consequences in the Human Brain (2002) (146)
- Tau and A&bgr;42 protein in CSF of patients with frontotemporal degeneration (2002) (143)
- Local Activity Determines Functional Connectivity in the Resting Human Brain: A Simultaneous FDG-PET/fMRI Study (2014) (140)
- Processing of histamine-induced itch in the human cerebral cortex: a correlation analysis with dermal reactions. (2000) (136)
- SNMMI Procedure Standard/EANM Practice Guideline for Amyloid PET Imaging of the Brain 1.0 (2016) (135)
- 18F-FDG PET studies in patients with extratemporal and temporal epilepsy: evaluation of an observer-independent analysis. (1999) (127)
- PSA-Stratified Performance of 18F- and 68Ga-PSMA PET in Patients with Biochemical Recurrence of Prostate Cancer (2017) (126)
- Schooling mediates brain reserve in Alzheimer’s disease: findings of fluoro-deoxy-glucose-positron emission tomography (2006) (123)
- White matter hyperintensities predict amyloid increase in Alzheimer's disease (2012) (122)
- Workflow and Scan Protocol Considerations for Integrated Whole-Body PET/MRI in Oncology (2012) (119)
- Within-patient correspondence of amyloid-β and intrinsic network connectivity in Alzheimer’s disease (2014) (118)
- Association of Cerebral Amyloid-&bgr; Aggregation With Cognitive Functioning in Persons Without Dementia (2018) (116)
- Aberrant Intrinsic Connectivity of Hippocampus and Amygdala Overlap in the Fronto-Insular and Dorsomedial-Prefrontal Cortex in Major Depressive Disorder (2013) (116)
- Cerebral glucose metabolism in patients with AD and different APOE genotypes (2005) (116)
- Small-Animal PET Imaging of Amyloid-Beta Plaques with [11C]PiB and Its Multi-Modal Validation in an APP/PS1 Mouse Model of Alzheimer's Disease (2012) (115)
- Metabolic Networks Underlying Cognitive Reserve in Prodromal Alzheimer Disease: A European Alzheimer Disease Consortium Project (2013) (114)
- Increased Intrinsic Brain Activity in the Striatum Reflects Symptom Dimensions in Schizophrenia (2012) (113)
- Long-Term Consequences of Switching Handedness: A Positron Emission Tomography Study on Handwriting in “Converted” Left-Handers (2002) (112)
- Resting metabolic connectivity in prodromal Alzheimer's disease. A European Alzheimer Disease Consortium (EADC) project (2012) (112)
- Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020. (2014) (108)
- Continuous Transcranial Magnetic Stimulation during Positron Emission Tomography: A Suitable Tool for Imaging Regional Excitability of the Human Cortex (2001) (107)
- Comparison of integrated whole-body [11C]choline PET/MR with PET/CT in patients with prostate cancer (2013) (107)
- NETWORKS OF TAU DISTRIBUTION IN ALZHEIMER’S DISEASE (2017) (106)
- Regional Expansion of Hypometabolism in Alzheimer's Disease Follows Amyloid Deposition with Temporal Delay (2012) (105)
- Progression of Cerebral Amyloid Load Is Associated with the Apolipoprotein E ε4 Genotype in Alzheimer's Disease (2010) (100)
- Clinical severity of Alzheimer's disease is associated with PIB uptake in PET (2009) (96)
- [German guidelines for brain tumour imaging by PET and SPECT using labelled amino acids]. (2011) (94)
- Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy (2020) (94)
- EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0 (2020) (93)
- Cerebral Metabolic Dysfunction in Patients with Dementia with Lewy Bodies and Visual Hallucinations (2008) (90)
- Resting-state functional reorganization in Parkinson's disease: An activation likelihood estimation meta-analysis (2017) (89)
- 18F-Labeled, PSMA-Targeted Radiotracers: Leveraging the Advantages of Radiofluorination for Prostate Cancer Molecular Imaging (2020) (88)
- Volume of interest-based [18F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study (2014) (87)
- In vivo Patterns of Tau Pathology, Amyloid-β Burden, and Neuronal Dysfunction in Clinical Variants of Alzheimer's Disease. (2016) (86)
- Mild cognitive impairment with suspected nonamyloid pathology (SNAP) (2015) (85)
- Short-term modulation of regional excitability and blood flow in human motor cortex following rapid-rate transcranial magnetic stimulation (2004) (83)
- A fronto-parietal network is mediating improvement of motor function related to repetitive peripheral magnetic stimulation: A PET-H2O15 study (2007) (82)
- Region-Specific Decline of Cerebral Glucose Metabolism in Patients with Frontotemporal Dementia: A Prospective 18F-FDG-PET Study (2004) (82)
- Positron emission tomography with [18F]FDG in the diagnosis of Creutzfeldt-Jakob disease (CJD) (2002) (81)
- Disrupted Intrinsic Networks Link Amyloid-β Pathology and Impaired Cognition in Prodromal Alzheimer's Disease. (2015) (80)
- Impact of tau and amyloid burden on glucose metabolism in Alzheimer's disease (2016) (80)
- European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18F‐fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus (2018) (80)
- The lower hippocampus global connectivity, the higher its local metabolism in Alzheimer disease (2015) (79)
- Clinical utility of FDG PET in Parkinson’s disease and atypical parkinsonism associated with dementia (2018) (76)
- Metabolic connectivity mapping reveals effective connectivity in the resting human brain (2015) (75)
- Metabolic connectivity: methods and applications (2017) (75)
- Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia (2018) (73)
- Gender differences in brain reserve (2007) (73)
- Metabolically stabilized benzothiazoles for imaging of amyloid plaques. (2007) (72)
- Primary Degenerative Mild Cognitive Impairment: Study Population, Clinical, Brain Imaging and Biochemical Findings (2001) (70)
- Effects of donepezil on cortical metabolic response to activation during 18FDG-PET in Alzheimer’s disease: a double-blind cross-over trial (2006) (70)
- Prostate-Specific Membrane Antigen PET/CT in Splenic Sarcoidosis. (2015) (69)
- The Whole-Brain "Global" Signal from Resting State fMRI as a Potential Biomarker of Quantitative State Changes in Glucose Metabolism (2016) (68)
- Current status and future role of brain PET/MRI in clinical and research settings (2015) (67)
- The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers (2021) (66)
- Visual versus semi-quantitative analysis of 18F-FDG-PET in amnestic MCI: an European Alzheimer's Disease Consortium (EADC) project. (2015) (65)
- A new integrative model of cerebral activation, deactivation and default mode function in Alzheimer’s disease (2008) (65)
- Combined PET/MRI: Multi-modality Multi-parametric Imaging Is Here (2015) (64)
- Limited agreement between biomarkers of neuronal injury at different stages of Alzheimer's disease (2014) (64)
- Potential Clinical Applications of PET/MR Imaging in Neurodegenerative Diseases (2014) (63)
- The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target Populations. (2014) (63)
- Synthesis and evaluation of 11C-labeled imidazo[2,1-b]benzothiazoles (IBTs) as PET tracers for imaging β-amyloid plaques in Alzheimer's disease. (2011) (62)
- EANM-EAN recommendations for the use of brain 18 F-Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) in neurodegenerative cognitive impairment and dementia: Delphi consensus (2018) (61)
- 18F-FDG PET Database of Longitudinally Confirmed Healthy Elderly Individuals Improves Detection of Mild Cognitive Impairment and Alzheimer's Disease (2007) (60)
- Lacrimal Glands May Represent Organs at Risk for Radionuclide Therapy of Prostate Cancer with [177Lu]DKFZ-PSMA-617 (2016) (59)
- Resting-State Connectivity of the Left Frontal Cortex to the Default Mode and Dorsal Attention Network Supports Reserve in Mild Cognitive Impairment (2017) (59)
- MR measurement of regional relative cerebral blood volume in epilepsy (1999) (58)
- Systematic Comparison of the Performance of Integrated Whole-Body PET/MR Imaging to Conventional PET/CT for 18F-FDG Brain Imaging in Patients Examined for Suspected Dementia (2014) (57)
- Development and evaluation of compounds for imaging of β-amyloid plaque by means of positron emission tomography (2008) (56)
- Assessment of tumor size reduction improves outcome prediction of positron emission tomography/computed tomography after chemotherapy in advanced-stage Hodgkin lymphoma. (2014) (55)
- Intraindividual Comparison of 18F-PSMA-1007 with Renally Excreted PSMA Ligands for PSMA PET Imaging in Patients with Relapsed Prostate Cancer (2019) (55)
- Metabolic and structural connectivity within the default mode network relates to working memory performance in young healthy adults (2013) (55)
- Clinical utility of FDG-PET for the clinical diagnosis in MCI (2018) (55)
- Resting-State Networks as Simultaneously Measured with Functional MRI and PET (2017) (53)
- Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases (2021) (53)
- Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer’s disease (2012) (52)
- Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease (2017) (52)
- [18F]Fluoroethylflumazenil: a novel tracer for PET imaging of human benzodiazepine receptors (2001) (52)
- Reduction of Benzodiazepine Receptor Binding is Related to the Seizure Onset Zone in Extratemporal Focal Cortical Dysplasia (2000) (51)
- Elevated in vivo [18F]‐AV‐1451 uptake in a patient with progressive supranuclear palsy (2017) (51)
- Based on the Network Degeneration Hypothesis: Separating Individual Patients with Different Neurodegenerative Syndromes in a Preliminary Hybrid PET/MR Study (2016) (51)
- Reference Cluster Normalization Improves Detection of Frontotemporal Lobar Degeneration by Means of FDG-PET (2012) (51)
- Effects of a 6-month cognitive intervention on brain metabolism in patients with amnestic MCI and mild Alzheimer's disease. (2011) (50)
- Imaging Frontotemporal Lobar Degeneration (2014) (49)
- Clinical Amyloid Imaging. (2017) (49)
- Brain reserve capacity in frontotemporal dementia: a voxel-based 18F-FDG PET study (2007) (48)
- Brain correlates of fast and slow handwriting in humans: a PET–performance correlation analysis (2001) (48)
- Impact of PET/CT image reconstruction methods and liver uptake normalization strategies on quantitative image analysis (2015) (48)
- CSF total and phosphorylated tau protein, regional glucose metabolism and dementia severity in Alzheimer’s disease (2008) (48)
- A Novel (18)F-Labeled Imidazo[2,1-b]benzothiazole (IBT) for High-Contrast PET Imaging of β-Amyloid Plaques. (2011) (48)
- Prostate-Specific Membrane Antigen–Targeted Radiohalogenated PET and Therapeutic Agents for Prostate Cancer (2016) (47)
- Gender differences in brain reserve : an (18)F-FDG PET study in Alzheimer's disease. (2007) (47)
- Early-Onset and Robust Amyloid Pathology in a New Homozygous Mouse Model of Alzheimer's Disease (2009) (46)
- Network degeneration in Parkinson's disease: multimodal imaging of nigro-striato-cortical dysfunction. (2020) (46)
- Quantitative longitudinal interrelationships between brain metabolism and amyloid deposition during a 2-year follow-up in patients with early Alzheimer’s disease (2012) (46)
- Non-fluent progressive aphasia: Cerebral metabolic patterns and brain reserve (2007) (45)
- Metabolic Tumor Volume for Response Prediction in Advanced-Stage Hodgkin Lymphoma (2018) (45)
- Combined PET/MR: Where Are We Now? Summary Report of the Second International Workshop on PET/MR Imaging April 8–12, 2013, Tubingen, Germany (2014) (45)
- The Functional Networks of Prepulse Inhibition: Neuronal Connectivity Analysis Based on FDG-PET in Awake and Unrestrained Rats (2016) (45)
- Impaired Cross-Modal Inhibition in Alzheimer Disease (2005) (44)
- Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum. (2022) (44)
- Longitudinal Changes of Cerebral Glucose Metabolism in Semantic Dementia (2006) (44)
- Prefrontal Hypometabolism in Alzheimer Disease Is Related to Longitudinal Amyloid Accumulation in Remote Brain Regions (2015) (44)
- Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment (2016) (43)
- 18F-fluorodeoxyglucose uptake pattern in patients with suspected spondylodiscitis (2013) (42)
- Engineered antibodies: new possibilities for brain PET? (2019) (42)
- The usefulness of amyloid imaging in predicting the clinical outcome after two years in subjects with mild cognitive impairment. (2013) (42)
- GBA Variants in Parkinson's Disease: Clinical, Metabolomic, and Multimodal Neuroimaging Phenotypes (2020) (41)
- 18F-FDG PET Detects Inflammatory Infiltrates in Spinal Cord Experimental Autoimmune Encephalomyelitis Lesions (2012) (41)
- Cerebral Metabolic Correlates of the Clinical Dementia Rating Scale in Mild Cognitive Impairment (2007) (41)
- Amyloid-plaque imaging in early and differential diagnosis of dementia (2010) (40)
- Activities of Daily Living, Cerebral Glucose Metabolism, and Cognitive Reserve in Lewy Body and Parkinson’s Disease (2008) (39)
- Diagnosis of Alzheimer’s Disease with [18F]PET in Mild and Asymptomatic Stages (2009) (39)
- Male gender is associated with greater cerebral hypometabolism in frontotemporal dementia: evidence for sex‐related cognitive reserve (2007) (39)
- Urinary incontinence and its functional anatomy in frontotemporal lobar degenerations (2008) (39)
- Metabolic connectivity for differential diagnosis of dementing disorders (2017) (39)
- Tau pathology and cognitive reserve in Alzheimer's disease (2017) (38)
- In vivo characterization of endothelial cell activation in a transgenic mouse model of Alzheimer’s disease (2006) (38)
- Dopamine metabolism of the nucleus accumbens and fronto-striatal connectivity modulate impulse control (2019) (37)
- Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders (2018) (36)
- Metabolic Correlates of Brain Reserve in Dementia with Lewy Bodies: An FDG PET Study (2007) (35)
- The need of standardization and of large clinical studies in an emerging indication of [18F]FDG PET: the autoimmune encephalitis (2016) (35)
- 2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework (2021) (34)
- Outcome-based interpretation of early interim PET in advanced-stage Hodgkin lymphoma. (2018) (34)
- Value of bone marrow biopsy in Hodgkin lymphoma patients staged by FDG PET: results from the German Hodgkin Study Group trials HD16, HD17, and HD18 (2018) (34)
- Medial Temporal Lobe Disconnection and Hyperexcitability Across Alzheimer’s Disease Stages (2019) (33)
- Discovery of 18F-JK-PSMA-7, a PET Probe for the Detection of Small PSMA-Positive Lesions (2018) (33)
- In Alzheimer's Disease, Hypometabolism in Low-Amyloid Brain Regions May Be a Functional Consequence of Pathologies in Connected Brain Regions (2014) (33)
- Effective connectivity in the default mode network is distinctively disrupted in Alzheimer's disease—A simultaneous resting‐state FDG‐PET/fMRI study (2019) (32)
- FDG and Amyloid PET in Cognitively Normal Individuals at Risk for Late-Onset Alzheimer’s Disease (2014) (32)
- Interpreting PET scans by structured patient data: a data mining case study in dementia research (2008) (31)
- Association between Cognitive Performance and Cortical Glucose Metabolism in Patients with Mild Alzheimer’s Disease (2005) (31)
- Tau-imaging in neurodegeneration. (2017) (31)
- Effects of a 6-month cognitive intervention program on brain metabolism in amnestic mild cognitive impairment and mild Alzheimer's disease. (2011) (31)
- Integrative analysis of blood metabolomics and PET brain neuroimaging data for Parkinson's disease (2019) (31)
- Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia (2018) (30)
- Relationship between occupation attributes and brain metabolism in frontotemporal dementia (2011) (30)
- Fluoro-deoxy-glucose positron emission tomography correlates of impaired activities of daily living in dementia with Lewy bodies: implications for cognitive reserve. (2009) (29)
- FIBT versus florbetaben and PiB: a preclinical comparison study with amyloid-PET in transgenic mice (2015) (29)
- Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer’s disease (2018) (29)
- Neuro-cognitive mechanisms of simultanagnosia in patients with posterior cortical atrophy. (2016) (29)
- Prevalence of abnormal Alzheimer’s disease biomarkers in patients with subjective cognitive decline: cross-sectional comparison of three European memory clinic samples (2019) (28)
- Early-phase [18F]PI-2620 tau-PET imaging as a surrogate marker of neuronal injury (2020) (28)
- Gaussian Mixture Models and Model Selection for [18F] Fluorodeoxyglucose Positron Emission Tomography Classification in Alzheimer’s Disease (2015) (28)
- Evaluation of the kappa-opioid receptor-selective tracer [11C]GR103545 in awake rhesus macaques (2010) (28)
- Association of the tau haplotype H2 with age at onset and functional alterations of glucose utilization in frontotemporal dementia. (2007) (28)
- AMYPAD Diagnostic and Patient Management Study: Rationale and design (2018) (27)
- Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System (2019) (26)
- Prominent hypometabolism of the right temporoparietal and frontal cortex in two left-handed patients with primary progressive aphasia (2002) (25)
- The frequency and influence of dementia risk factors in prodromal Alzheimer's disease (2017) (24)
- Cortical [18F]PI‐2620 Binding Differentiates Corticobasal Syndrome Subtypes (2021) (24)
- Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington’s disease (2018) (23)
- Clinical validity of increased cortical uptake of [18F]flortaucipir on PET as a biomarker for Alzheimer’s disease in the context of a structured 5-phase biomarker development framework (2021) (23)
- PET imaging of gliomas using novel tracers: a sleeping beauty waiting to be kissed (2010) (23)
- Evaluation of several multi-atlas methods for PSEUDO-CT generation in brain MRI-PET attenuation correction (2015) (23)
- The Network Degeneration Hypothesis: Spread of Neurodegenerative Patterns Along Neuronal Brain Networks (2018) (23)
- Combined Early and Late [68Ga]PSMA-HBED-CC PET Scans Improve Lesion Detectability in Biochemical Recurrence of Prostate Cancer with Low PSA Levels (2018) (23)
- FDG-PET underscores the key role of the thalamus in frontotemporal lobar degeneration caused by C9ORF72 mutations (2019) (22)
- Asymmetric Loss of Parietal Activity Causes Spatial Bias in Prodromal and Mild Alzheimer's Disease (2012) (22)
- 18-Fluorodeoxyglucose positron emission tomography/computed tomography for assessment of response to brentuximab vedotin treatment in relapsed and refractory Hodgkin lymphoma (2014) (22)
- Metabolic Topology of Neurodegenerative Disorders: Influence of Cognitive and Motor Deficits (2015) (21)
- A perspective on the future role of brain pet imaging in exercise science (2016) (21)
- LRP-1 polymorphism is associated with global and regional amyloid load in Alzheimer's disease in humans in-vivo (2014) (21)
- Clinical validity of second-generation tau PET tracers as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework (2021) (21)
- Characterization of SnO2-based 68Ge/68Ga generators and 68Ga-DOTATATE preparations: radionuclide purity, radiochemical yield and long-term constancy (2014) (21)
- Right prefrontal hypometabolism predicts delusions in dementia with Lewy bodies (2009) (21)
- Small Vessel Disease, but Neither Amyloid Load nor Metabolic Deficit, Is Dependent on Age at Onset in Alzheimer’s Disease (2015) (21)
- The default mode network and cognition in Parkinson's disease: A multimodal resting‐state network approach (2021) (21)
- Deferoxamine improves coronary vascular responses to sympathetic stimulation in patients with type 1 diabetes mellitus (2002) (20)
- Reduced blood oxygenation level dependent connectivity is related to hypoperfusion in Alzheimer’s disease (2019) (20)
- Voxel-Based Analysis of Amyloid-Burden Measured with [11C]PiB PET in a Double Transgenic Mouse Model of Alzheimer’s Disease (2013) (20)
- EBONI: A Tool for Automated Quantification of Bone Metastasis Load in PSMA PET/CT (2017) (20)
- Extended Postinterventional Tumor Necrosis—Implication for Outcome in Liver Transplant Patients with Advanced HCC (2013) (20)
- Amyloid cascade and tau pathology cerebrospinal fluid markers in mild cognitive impairment with regards to Alzheimer's disease cerebral metabolic signature. (2013) (19)
- Is Tau Imaging More Than Just Upside-Down 18F-FDG Imaging? (2017) (19)
- A Matter of Controversy: Is Radioiodine Therapy Favorable in Differentiated Thyroid Carcinoma? (2018) (19)
- Characterization and first human investigation of FIBT, a novel fluorinated Aβ plaque neuroimaging PET radioligand. (2015) (18)
- The role of biological markers in the early and differential diagnosis of Alzheimer's disease. (2002) (18)
- Quantitative amyloid PET in Alzheimer's disease: the AMYPAD prognostic and natural history study (2020) (18)
- Synthesis and evaluation of a full-agonist orvinol for PET-imaging of opioid receptors: [11C]PEO. (2009) (18)
- Kinetic modelling of [11C]flumazenil using data-driven methods (2009) (17)
- PET in patients with clear-cut multiple chemical sensitivity (MCS) (2002) (17)
- Brain Metabolic Correlates of Cerebrospinal Fluid Beta-Amyloid 42 and Tau in Alzheimer’s Disease (2009) (17)
- Binding characteristics of [18F]PI-2620 distinguish the clinically predicted tau isoform in different tauopathies by PET (2021) (17)
- Neuropsychological and positron emission tomography correlates in idiopathic environmental intolerances. (2007) (17)
- An 18F-Labeled PSMA Ligand for PET/CT of Prostate Cancer: First-in-Humans Observational Study and Clinical Experience with 18F-JK-PSMA-7 During the First Year of Application (2020) (16)
- Connectomics and molecular imaging in neurodegeneration (2019) (16)
- Biodistribution and radiation dosimetry of [18F]-JK-PSMA-7 as a novel prostate-specific membrane antigen-specific ligand for PET/CT imaging of prostate cancer (2019) (16)
- The strategic biomarker roadmap for the validation of Alzheimer’s diagnostic biomarkers: methodological update (2021) (16)
- One-Stop Shop: 18F-Flortaucipir PET Differentiates Amyloid-Positive and -Negative Forms of Neurodegenerative Diseases (2020) (16)
- An Efficient Approach to Perform MR-Assisted PET Data Optimization in Simultaneous PET/MR Neuroimaging Studies (2018) (15)
- Coronary microvascular reactivity to sympathetic stimulation in patients with idiopathic dilated cardiomyopathy. (2000) (15)
- Impulsivity is Associated with Increased Metabolism in the Fronto-Insular Network in Parkinson’s Disease (2015) (15)
- Atypical parkinsonism due to a D202N Gerstmann‐Sträussler‐Scheinker prion protein mutation: First in vivo diagnosed case (2013) (15)
- Molecular imaging in dementia (2008) (15)
- Basic pathologies of neurodegenerative dementias and their relevance for state-of-the-art molecular imaging studies (2008) (15)
- Multimodal correlation of dynamic [18F]-AV-1451 perfusion PET and neuronal hypometabolism in [18F]-FDG PET (2017) (14)
- Concept of functional imaging of memory decline in Alzheimer's disease. (2008) (13)
- A case of multimodality multiparametric 11C-choline PET/MR for biopsy targeting in prior biopsy-negative primary prostate cancer. (2012) (13)
- Feasibility of short imaging protocols for [18F]PI-2620 tau-PET in progressive supranuclear palsy (2021) (13)
- A New Method for Radiosynthesis of 11C-Labeled Carbamate Groups and its Application for a Highly Efficient Synthesis of the Kappa-Opioid Receptor Tracer [11C]GR103545 (2008) (13)
- Comparison of 18F-T807 and 18F-THK5117 PET in a Mouse Model of Tau Pathology (2018) (13)
- Spinal long‐term potentiation is associated with reduced opioid neurotransmission in the rat brain (2010) (13)
- Molecular neuroimaging with PET/MRI (2013) (12)
- Cerebrospinal Fluid BACE1 Activity and Brain Amyloid Load in Alzheimer's Disease (2012) (12)
- Motor impairment and compensation in a hemiparkinsonian rat model: correlation between dopamine depletion severity, cerebral metabolism and gait patterns (2017) (12)
- Abnormal Regional and Global Connectivity Measures in Subjective Cognitive Decline Depending on Cerebral Amyloid Status. (2020) (12)
- Clinical Experience with 18F-Labeled Small Molecule Inhibitors of Prostate-Specific Membrane Antigen. (2017) (12)
- Level of education mitigates the impact of tau pathology on neuronal function (2019) (12)
- The Role of Tau Imaging in Parkinsonian Disorders (2018) (12)
- Metabolic alterations associated with impaired clock drawing in Lewy body dementia (2010) (11)
- Head-to-Head Comparison among Semi-Quantification Tools of Brain FDG-PET to Aid the Diagnosis of Prodromal Alzheimer's Disease. (2019) (11)
- Clinical significance of urokinase-type plasminogen activator (uPA) and its type-1 inhibitor (PAI-1) for metastatic sentinel lymph node involvement in breast cancer. (2014) (11)
- Repair of Cerebrospinal Fluid Leakage Using a Transfrontal, Radial Adipofascial Flap: An Individual Approach Supported by Three-Dimensional Printing for Surgical Planning. (2018) (10)
- Development of an improved radioiodinated 2-phenylimidazo[1,2-a]pyridine for non-invasive imaging of amyloid plaques (2012) (10)
- [Lutetium-177-PSMA radioligand therapy : Consensus within the framework of GKV-funded care between the university hospitals in Aachen, Bonn, Düsseldorf, Essen, and Cologne and the MDK Nordrhein]. (2018) (10)
- Mars Shot for Nuclear Medicine, Molecular Imaging, and Molecularly Targeted Radiopharmaceutical Therapy (2020) (10)
- Quantitative assessment of 18F-FDG PET in patients with Hodgkin lymphoma: is it significantly affected by contrast-enhanced computed tomography attenuation correction? (2019) (9)
- Prognostic value of Alzheimer’s biomarkers in mild cognitive impairment: the effect of age at onset (2019) (9)
- Lutetium-177-PSMA-Radioligandentherapie (2018) (9)
- A Case Study of Stacked Multi-view Learning in Dementia Research (2011) (9)
- Monitoring Treatment Response to Erlotinib in EGFR‐mutated Non–small‐cell Lung Cancer Brain Metastases Using Serial O‐(2‐[18F]fluoroethyl)‐L‐tyrosine PET (2019) (9)
- Overlapping and distinct neural metabolic patterns related to impulsivity and hypomania in Parkinson’s disease (2019) (8)
- Diagnostic Value of Subjective Memory Complaints Assessed with a Single Item in Dominantly Inherited Alzheimer's Disease: Results of the DIAN Study (2015) (8)
- Successful Yttrium-90 Microsphere Radioembolization for Hepatic Metastases of Prostate Cancer (2017) (8)
- An 89Zr-Labeled PSMA Tracer for PET/CT Imaging of Prostate Cancer Patients (2021) (8)
- Impact of different approaches to calculation of treatment activities on achieved doses in radioiodine therapy of benign thyroid diseases (2018) (7)
- Biodistribution and radiation dosimetry of the novel 18F-labeled prostate-specific membrane antigen-ligand PSMA-7 for PET/CT in prostate cancer patients (2018) (7)
- Efficient redundancy reduced subgroup discovery via quadratic programming (2012) (7)
- Molecular imaging in early diagnosis, differential diagnosis and follow-up of patients with neurodegenerative diseases (2017) (7)
- Local and Global Changes in Brain Metabolism during Deep Brain Stimulation for Obsessive-Compulsive Disorder (2019) (7)
- Indication of retrograde tau spreading along Braak stages and functional connectivity pathways (2021) (7)
- Pentixafor PET/CT for imaging of chemokine receptor 4 expression in esophageal cancer – a first clinical approach (2021) (7)
- 18F-FIBT may expand PET for β-amyloid imaging in neurodegenerative diseases (2018) (7)
- Editorial: Utilization of Hybrid PET/MR in Neuroimaging (2015) (7)
- Effects of subthalamic deep brain stimulation on striatal metabolic connectivity in a rat hemiparkinsonian model (2019) (7)
- Mechanisms and modulators of cognitive training gain transfer in cognitively healthy aging: study protocol of the AgeGain study (2018) (7)
- Translational Development of a Zr-89-Labeled Inhibitor of Prostate-specific Membrane Antigen for PET Imaging in Prostate Cancer (2021) (7)
- Mechanisms and modulators of cognitive training gain transfer in cognitively healthy aging: study protocol of the AgeGain study (2018) (7)
- Unique regional patterns of amyloid burden predict progression to prodromal and clinical stages of Alzheimer's disease (2021) (6)
- 18F-PI2620 TAU-PET IN PROGRESSIVE SUPRANUCLEAR PALSY: A MULTI-CENTER EVALUATION (2019) (6)
- Assessing accuracy diagnostic FDG-PET studies to define clinical use for dementia diagnosis (2018) (6)
- Toward a Universal Readout for 18F-Labeled Amyloid Tracers: The CAPTAINs Study (2021) (6)
- 18F-PI2620 TAU-PET IN PROGRESSIVE SUPRANUCLEAR PALSY: A MULTI-CENTER EVALUATION (2019) (6)
- Dopaminergic pathways and resting-state functional connectivity in Parkinson’s disease with freezing of gait (2021) (6)
- Solitary PSMA-Positive Pulmonary Metastasis in Biochemical Relapse of Prostate Cancer. (2017) (6)
- Assessment of Tau Tangles and Amyloid-β Plaques Among Super Agers Using PET Imaging (2020) (6)
- [18F]-JK-PSMA-7 PET/CT Under Androgen Deprivation Therapy in Advanced Prostate Cancer (2020) (6)
- Uncovering an Optic Nerve Sheath Meningioma Using 68Ga-DOTATATE PET/CT. (2021) (5)
- Thyroid hemiagenesis is combined with a variety of thyroid disorders (2019) (5)
- Individualized treatment of differentiated thyroid cancer: The value of surgery in combination with radioiodine imaging and therapy - A German position paper from Surgery and Nuclear Medicine. (2022) (5)
- 18F-FDG PET Imaging in Neurodegenerative Dementing Disorders: Insights into Subtype Classification, Emerging Disease Categories, and Mixed Dementia with Copathologies. (2022) (5)
- Retention efficacy and release of radioiodine in fume hoods. (2017) (5)
- PET Amyloid imaging and cognition in patients with Alzheimer's disease, Mild Cognitive Impairment (MCI) and healthy controls: a European multicenter study (2009) (5)
- Dual-Tracer PET/CT Protocol with [18F]-FDG and [68Ga]Ga-FAPI-46 for Cancer Imaging: A Proof of Concept (2022) (5)
- [German Society of Nuclear Medicine procedure guideline on beta-amyloid brain PET imaging]. (2016) (5)
- Finding our way through the labyrinth of dementia biomarkers (2021) (5)
- Uptake in non-affected bone tissue does not differ between [18F]-DCFPyL and [68Ga]-HBED-CC PSMA PET/CT (2018) (5)
- Clinical validity of increased cortical binding of tau ligands of the THK family and PBB3 on PET as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework (2021) (5)
- Thyroid Uptake and Effective Half-Life of Radioiodine in Thyroid Cancer Patients at Radioiodine Therapy and Follow-Up Whole-Body Scintigraphy Either in Hypothyroidism or Under rhTSH (2018) (5)
- Concordance in the interpretation of PET after chemotherapy in advanced stage Hodgkin lymphoma (2015) (4)
- A Comparison of Two Statistical Mapping Tools for Automated Brain FDG-PET Analysis in Predicting Conversion to Alzheimer's Disease in Subjects with Mild Cognitive Impairment. (2021) (4)
- Exhalation of 131I after radioiodine therapy: Dosimetric considerations based on measurements in exhaled air. (2017) (4)
- Tau pathology in Huntington's disease: A brief in vivo PET-imaging report (2017) (4)
- Positron-Emission-Tomography Imaging of Long-Term Expression of the 18kDa Translocator Protein After Sudden Cardiac Arrest in Rats. (2020) (4)
- 4D-CT-based motion correction of PET images using 3D iterative deconvolution (2019) (4)
- Erratum to: The need of standardization and of large clinical studies in an emerging indication of [18F]FDG PET: the autoimmune encephalitis (European Journal of Nuclear Medicine and Molecular Imaging, (2017), 44, 3, (353-357), 10.1007/s00259-016-3589-9) (2017) (4)
- The patient as a radioactive source: an intercomparison of survey meters for measurements in nuclear medicine. (2014) (4)
- T 1-mapping and dielectric properties evaluation of a 3D printable rubber-elastomeric polymer as tissue mimicking materials for MRI phantoms (2020) (4)
- Orbital Hemangiopericytoma in 68Ga-Prostate-Specific Membrane Antigen-HBED-CC PET/CT. (2017) (4)
- Description of a European memory clinic cohort undergoing amyloid‐PET: The AMYPAD Diagnostic and Patient Management Study (2022) (4)
- Imaging in Neurology Research II: PET Imaging of CNS Disorders (2011) (4)
- Head-to-Head Comparison of [68 Ga]Ga-FAPI-46-PET/CT and [18F]F-FDG-PET/CT for Radiotherapy Planning in Head and Neck Cancer (2022) (4)
- Comparing propofol versus sevoflurane anesthesia for epileptogenic focus detection during positron emission tomography in pediatric patients. (2013) (4)
- Future Directions in Molecular Imaging of Neurodegenerative Disorders. (2022) (3)
- Brain Glucose Metabolism in Parry-Romberg Syndrome. (2017) (3)
- Finding New Communities: A Principle of Neuronal Network Reorganization in Alzheimer's Disease (2020) (3)
- [Dopamine Transporter SPECT with I-123 labelled FP-CIT (DaTSCANTM)]. (2019) (3)
- Evaluation of 3D printable rubber-elastomeric polymer as phantom material for Hybrid PET/MRI (2019) (3)
- Complete Remission of Metastatic Neuroendocrine Paragastric Carcinoma After "Neoadjuvant" Peptide Receptor Radionuclide Therapy and Surgery. (2015) (3)
- Integrated simultaneous whole-body MR/PET: First comparison between MR/PET and PET/CT in patients (2011) (3)
- PET/MR in Brain Imaging (2014) (3)
- Frontal diaschisis in a German case of fatal familial insomnia (2006) (3)
- The effectiveness of wastewater treatment in nuclear medicine: Performance data and radioecological considerations. (2017) (3)
- Reply: SPECT/CT (2009) (3)
- A novel 18 F ‐ labeled PSMA ligand for PET/CT imaging of prostate cancer patients: First ‐ in ‐ man observational study and clinical experience with 18 F ‐ JK ‐ PSMA ‐ 7 during the first year of application (2019) (3)
- Lymph Node Assessment in Prostate Cancer: Evaluation of Iodine Quantification With Spectral Detector CT in Correlation to PSMA PET/CT. (2021) (3)
- Additive value of [18F]PI-2620 perfusion imaging in progressive supranuclear palsy and corticobasal syndrome (2022) (3)
- Evaluation of 3-l- and 3-d-[18F]Fluorophenylalanines as PET Tracers for Tumor Imaging (2021) (3)
- The Default Network of the Brain (2020) (3)
- Beta-Amyloid-PET-Bildgebung des Gehirns (2016) (3)
- [Visualization of amyloid with positron emission tomography. Useful improvement in the diagnosis of dementia?]. (2010) (3)
- Oligometastatic disease in biochemical recurrence of prostate cancer: Prevalence on PSMA PET/CT and consecutive metastasis-directed therapy - Experience at a tertiary referral center. (2022) (3)
- Functional imaging of residual “left-handedness” in converted left-handers (2001) (2)
- Feasibility of in vivo amyloid plaque imaging in a transgenic mouse model of Alzheimer's disease (2007) (2)
- Erratum to: The need of standardization and of large clinical studies in an emerging indication of [18 F]FDG PET: the autoimmune encephalitis (2016) (2)
- Treatment outcome and identification of factors influencing overall survival after Lu-177-PSMA-617 radioligand therapy in metastatic prostate cancer. (2021) (2)
- [Taste dysfunction (dysgeusia) and radioiodine therapy of thyroid cancer - Be aware of side effects by antidepressants and sedatives]. (2017) (2)
- Overcoming acquired osimertinib-resistance in EGFR-mutant advanced non-small lung cancer mediated by activating BRAF V600E mutation. (2019) (2)
- [Taste dysfunction (dysgeusia) and radioiodine therapy of thyroid cancer - be aware of side effects by antidepressants and sedatives. Vorschädigung durch Antidepressiva und Sedativa beachten]. (2017) (2)
- Clear‐headed into old age: Resilience and resistance against brain aging—A PET imaging perspective (2022) (2)
- Evaluation of the qualitative performance of PET/MR versus PET/CT in patients with Alzheimer's disease (2012) (2)
- Imaging of cerebral tryptophan metabolism using 7-[18F]FTrp-PET in a unilateral Parkinsonian rat model (2021) (2)
- Alzheimer’s disease biomarker roadmap 2020: Second‐generation tau PET tracers (2020) (2)
- The effect of partial volume effect correction on PIB and FDG PET data in MCI and AD patients (2009) (2)
- Evaluation of Navigated Beta-Probe Surface Imaging on a Realistic 3D Phantom (2011) (2)
- Neural correlates and predictors of subjective cognitive decline in patients with Parkinson’s disease (2021) (2)
- Dnmt3a2/Dnmt3L Overexpression in the Dopaminergic System of Mice Increases Exercise Behavior through Signaling Changes in the Hypothalamus (2020) (2)
- Entorhinal Tau Predicts Hippocampal Activation and Memory Deficits in Alzheimer's Disease. (2020) (2)
- Alzheimer’s disease biomarker roadmap 2020: Fluid biomarkers (2020) (2)
- Influence of iodine supply on the radiation-induced DNA-fragmentation. (2017) (2)
- Discovery of F-18-JK-PSMA-7 as PET-probe suitable for imaging of small PSMA expressing lesions (2019) (2)
- Assessment of the In Vivo Relationship Between Cerebral Hypometabolism, Tau Deposition, TSPO Expression, and Synaptic Density in a Tauopathy Mouse Model: a Multi-tracer PET Study (2022) (2)
- Comparison of F-18 FDG-PET and C-11 FMZ-PET in extratemporal epilepsy with MRI, EEG and postoperative analysis of resected brain tissue (1998) (2)
- Peak Location of Amyloid PET Tracer Uptake within Cortical Gray Matter: Topographic Patterns and Diagnostic Application in Alzheimer's Disease (2016) (2)
- The biomarker roadmap for the validation for Alzheimer’s biomarkers: Methodological update for biomarkers of tauopathy (2020) (2)
- Quantitative amyloid PET in the AMYPAD diagnostic and patient management study (2021) (1)
- The amyloid imaging for the prevention of Alzheimer's disease consortium: A European collaboration with global impact (2023) (1)
- Alzheimer’s disease biomarker roadmap 2020: Time for tau (2020) (1)
- Resting brain metabolic connectivity in prodromal Alzheimer's disease: Evidence for early functional disconnection–An EADC joint project. (2011) (1)
- Parkinson's disease with a predominant right-sided putaminal FP-CIT SPECT deficiency shows stronger decline of asymmetry over time (2014) (1)
- The 18F-labeled PSMA_6 compares favorably to 68Ga-labeled PSMA-HBED-CC. A first clinical study in patients with relapsed prostate cancer (2015) (1)
- [18F-FDG PET/CT in head and neck tumors]. (2020) (1)
- [The importance of molecular imaging (PET) in the diagnostics of dementia]. (2018) (1)
- Application of 18F-labeled PSMA-imaging using [18F]DCFPyL at very low PSA-values may allow curative treatment in recurrent prostate cancer (2016) (1)
- The Concept of Motor Reserve in Parkinson's Disease: New Wine in Old Bottles? (2022) (1)
- [Recommendation for the differentiated use of nuclear medical diagnostic for parkinsonian syndromes]. (2020) (1)
- Functional and metabolic resting state networks as captured with simultaneous PET/MR imaging (2013) (1)
- Differences of cerebral activation between healthy volunteers and patients with MCI and Alzheimer's disease during navigation in a virtual reality environment. An O15-water PET activation study. (2003) (1)
- Towards chronic deep brain stimulation in freely moving hemiparkinsonian rats: applicability and functionality of a fully implantable stimulation system (2021) (1)
- Comparing Amyloid PET Tracers and Interpretation Strategies: First Results from the CAPTAINs Study (2018) (1)
- One stop shop: Flortaucipir PET pattern predicts amyloid positivity in neurodegenerative diseases (2019) (1)
- Neuroanatomy of cognition, delusions and visual hallucinations in Lewy body and Parkinson's disease dementia (2008) (1)
- Regional expansion of hypometabolism and amyloid deposition in AD and their relation to functional connectivity networks in healthy controls (2011) (1)
- In vivo Tau-PET indicates expansion of tau pathology within the default mode network in Alzheimer's disease (2015) (1)
- P1-247: Clinical severity of Alzheimer's disease is associated with PIB uptake in PET (2008) (1)
- Additive value of [18F]PI-2620 perfusion imaging in four-repeat tauopathies (2022) (1)
- Frequency-dependent increase of regional cerebral blood flow in the human sensorimotor cortex during rhythmic transcranial magnetic stimulation—a parametric PET study (2000) (1)
- Impaired self-awareness of cognitive deficits in Parkinson's disease relates to cingulate cortex dysfunction (2021) (1)
- Heterogeneity in cerebral metabolism in patients with mild cognitive impairment: A pet study (2000) (1)
- Is there an additional benefit of Tc-99m-PSMA-guided gamma probe use for salvage lymph node dissection in recurrent prostate cancer. (2017) (1)
- First Clinical Experience With [68Ga]Ga-FAPI-46-PET/CT Versus [18F]F-FDG PET/CT for Nodal Staging in Cervical Cancer (2022) (1)
- FDG-PET-Imaging for Diagnosis of Dementia (2012) (1)
- Structural and Functional Magnetic Resonance Imaging: Mild Cognitive Impairment and Alzheimer Disease. (2013) (1)
- Oral Presentations_Tuesday (2009) (1)
- An inpainting approach for the correction of incomplete attenuation maps in PET/MR (2010) (1)
- Spontaneous Low-Frequency BOLD Signal Fluctuations : Changes in Default Mode Network in Brain Diseased with Glioblastoma (2009) (1)
- Alzheimer’s disease biomarker roadmap 2020: [ 18 F]flortaucipir: Strategic roadmap for the translation of tau biomarkers in the clinic: An international task force (2020) (1)
- Image-Derived Input Functions for Quantification of A1 Adenosine Receptors Availability in Mice Brains Using PET and [18F]CPFPX (2020) (1)
- Positron Emission Tomography of the Human Brain in an Experimental Itch Model (2001) (1)
- Progression of cerebral amyloid load in Alzheimer's disease is associated with the apolipoprotein E E-ε4 genotype (2010) (1)
- Molecular Imaging and Precision Medicine in Dementia and Movement Disorders. (2017) (1)
- Inverse relationship between energetic costs and functional connectivity in human brain networks (2014) (1)
- Proven validity and management impact of amyloid imaging in Alzheimer’s disease—repetita juvant (2020) (1)
- Subthreshold repetitive TMS induces a lasting modulation of regional cerebral blood flow in the stimulated cortex (2001) (1)
- PET and SPECT Imaging of Neurodegenerative Diseases (2021) (1)
- Avoidance of iodine deficiency/excess during pregnancy in Hashimoto’s thyroiditis (2021) (1)
- Radiological characteristics of a new experimental rubber elastomeric polymer used in three-dimensional printing with different infill densities and patterns (2020) (1)
- 18F‐PI‐2620 tau‐PET in corticobasal syndrome (ActiGliA cohort) (2020) (1)
- D26 Pathological tau signal in huntington’s disease – an in vivo [18F]-AV-1451 pet imaging report (2016) (1)
- Global phase 2b efficacy and safety trial of florbetaben for beta-amyloid brain positron emission tomography in Alzheimer's disease (2011) (1)
- Neprilysin activity in CSF is associated with CSF tau but neither with cerebral amyloid load nor CSF amyloid 1-42 in Alzheimer's disease (2013) (0)
- P1-467 TAU PATHOLOGY BURDEN ASSOCIATED WITH LEVELOF COGNITIVE RESERVE IN ALZHEIMER’S DISEASE (2017) (0)
- Global phase 2b trial on florbetaben for {beta}-amyloid brain PET in Alzheimer's disease (2011) (0)
- P3-056 Decline of cerebral metabolism in the course of frontotemporal dementia. A prospective FDG-PET study (2004) (0)
- PET/CT Reconstruction and Its Impact on Quantitative Image Analysis (2015) (0)
- Characterization of functional neural networks using [18F]fluorodeoxyglucose (FDG)-PET in awake rats (2015) (0)
- TIP 2.0: A one-click software package for dynamic brain PET image processing and kinetic modeling (2021) (0)
- Early-Phase F-18-PI-2620 Tau-PET Imaging as a Surrogate Marker of Neurodegeneration (2019) (0)
- Amyloid deposition predicts regional and quantitative metabolic decline in patients with mild Alzheimer's disease (2011) (0)
- Beta-Amyloid PET Imaging in Alzheimers Disease in a Close to Clinical Routine Situation - Results of a Multi- Center Phase 2 Trial (2013) (0)
- Tau spreading facilitated by distinct regional amyloid patterns in aging and Alzheimer’s disease (2022) (0)
- Reversal of tau-dependent cognitive decay by blocking adenosine A1 receptors in mouse models of tauopathy (2022) (0)
- Slowly progressing logopenic aphasia in a patient with a TREM2 (p.T96K) mutation (2015) (0)
- Cognitive reserve in non-Alzheimer's dementias (2009) (0)
- Simultaneous [18F]FET PET/MR in cerebral tumors. Comparison with conventional PET/CT (2012) (0)
- Tau pathology associated with level of cognitive reserve in Alzheimer’s disease. (2017) (0)
- 2016 SNMMI Highlights Lecture: Neurosciences. (2016) (0)
- In Alzheimer's disease, hypometabolism in brain regions less affected by amyloid-pathology may be a consequence of pathologies in functionally connected brain regions (2012) (0)
- In Alzheimer's disease aberrant functional brain network connectivity is regionally consistent across cognitive states and related with amyloid density (2012) (0)
- Detection of cell-free HPV16-DNA in liquid biopsy – A promising biomarker for patients with HPV-related oropharyngeal squamous cell carcinoma (2021) (0)
- Region-Specific Decline of Cerebral Glucose Metabolism in Patients with Frontotemporal Dementia: A Prospective textsuperscript18F-FDG-PET Study (2004) (0)
- IC-102-03 Assessment of cerebral hypometabolism and amyloid plaque load in semantic dementia and dementia of the Alzheimer type (2006) (0)
- 2017 SNMMI Highlights Lecture: Neuroscience. (2017) (0)
- PREDICTION OF DEMENTIA DUE TO AD IN MCI USING FDG AND AMYLOID-PET: VISUAL VS. FULLY-AUTOMATED ANALYSES (2014) (0)
- JAMA Paper supplement (2015) (0)
- Improved SUVR calculation for [18F]-AV45 amyloid PET imaging using a novel reference region approach (2022) (0)
- Graph theoretical analysis of tau burden and the functional connectome in Alzheimers disease (2019) (0)
- Subject Index Vol. 12, 2001 (2001) (0)
- 18 F-PI2620 Tau-PET for Assessment of Heterogeneous Neuropathology in Corticobasal Syndrome (2020) (0)
- Correction to: The Strategic Biomarker Roadmap for the validation of Alzheimer’s diagnostic biomarkers: methodological update (2021) (0)
- TIP: A diagnostic tool to create 3D deviation maps and brain surface views from F18-AV1451-PET data (2016) (0)
- NETWORKS OF TAU DISTRIBUTION IN ALZHEIMER’S DISEASE (2017) (0)
- In vivo correlations of BACE1 activity with markers of APP metabolism and axonal degeneration (2012) (0)
- Subject Index Vol. 23, 2007 (2007) (0)
- HIPPOCAMPAL INTRINSIC CONNECTIVITY SUPPORTS COGNITIVE RESERVE IN AMYLOID-POSITIVE COGNITIVELY NORMAL SUBJECTS AND ALZHEIMER’S DISEASE PATIENTS (2019) (0)
- Diagnostic utility of FDG-PET in asymptomatic subjects at increased risk for Alzheimer’s disease (2018) (0)
- Head-to-Head Comparison among Semi-Quantification Tools of Brain FDG-PET to Aid the Diagnosis of Prodromal Alzheimer's Disease. (2020) (0)
- Prediction of progression to dementia in patients with mild cognitive impairment combining FDG-PET imaging with apolipoprotein E genotyping (2005) (0)
- Comparison of intergrated [11C]choline PET/MR with PET/CT in patients with prostate cancer (2012) (0)
- Brain atrophy, hypometabolism and amyloid deposition in early AD: A longitudinal multimodal study (2012) (0)
- Correction: Individualized treatment of differentiated thyroid cancer: The value of surgery in combination with radioiodine imaging and therapy - A German position paper from Surgery and Nuclear Medicine. (2022) (0)
- fMRI-based decoding of the modified default-mode network in mild cognitive impairment (2006) (0)
- IC-P1-045: Right prefrontal hypometabolism predicts delusions in dementia with Lewy bodies (2008) (0)
- In vivo assessment of cerebral glucose metabolism using F-18 FDG PET in a transgenic mouse model of Alzheimer's disease (2004) (0)
- PET/MRT in der Diagnostik gastrointestinaler Tumoren (2012) (0)
- JAMA Neurology Peer Reviewers in 2017. (2018) (0)
- P3-425 Effects of donepezil on cortical metabolic response to activation during 18FDG-PET in Alzheimer’s disease: A double-blind cross-over trial (2006) (0)
- P2-243 Longitudinal changes of cerebral glucose metabolism in semantic dementia (2006) (0)
- Localisation of the epileptogenic zone in adults by 3D image registration of [C-11]-flumazenil-PET and MRI: Comparison with subdural EEG recordings (2005) (0)
- EANM / EANO / RANO practice guidelines / SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [ F-18 ] FDG (2019) (0)
- PET tracers against the prostate-specific membrane antigen (PSMA) for localization of relapsed prostate cancer in patients with renewed increase in the prostate-specific antigen (PSA), (2016) (0)
- Lack of agreement between biomarkers of neuronal injury in ADNI (2013) (0)
- COVARIANCE-BASED DIFFERENTIATION OF DEMENTIA FORMS USING POSITRON EMISSION TOMOGRAPHY (2014) (0)
- Changes in cerebral glucose metabolism and functional whole brain connectivity in relation to {beta}-amyloid load in pre-dementia stages of Alzheimer's disease (2010) (0)
- P1.097 Brain functional correlates of geriatric assessment in dementia with Lewy bodies (2009) (0)
- In vivo PET imaging of {beta}-amyloid plaques in an APP/PS1 mouse model of Alzheimer's disease: Comparison of [18F]FIBT and [18F]Florbetaben with [11C]PiB (2012) (0)
- Entorhinal tau is associated with increased hippocampal activation and memory deficits in Alzheimer’s disease (2020) (0)
- Steps towards the implementation of amyloid‐PET in memory clinics: AMYPAD Diagnostic and Patient Management Study (2022) (0)
- S.23.04 Multimodal imaging of neuronal function and dysfunction (2013) (0)
- emission tomography disease : findings of fluoro-deoxy-glucose-positron Schooling mediates brain reserve in Alzheimer ’ s (2006) (0)
- METHODOLOGICAL AND LOGISTIC STRATEGIES FOR A LARGE MULTI-CENTER β-AMYLOID PET EUROPEAN PROJECT: AMYLOID IMAGING TO PREVENT ALZHEIMER’S DISEASE (AMYPAD) (2017) (0)
- Improved Imaging-Based Diagnosis of PSP by [F-18]PI-2620 Tau PET (2020) (0)
- THE CAPTAINS STUDY: STANDARDIZING VISUAL INTERPRETATION STRATEGIES FOR AMYLOID PET TRACERS (2019) (0)
- Neoadjuvant hemi-liver directed selective internal radiation therapy (SIRT) followed by portal vein and liver vein embolization could make non-operable patients with liver cancer eligible for curative intended major liver resection (2022) (0)
- Imaging Amyloid in the Human Brain: A Promising Tool for Improved Early Diagnosis and Treatment Monitoring in Alzheimer`s Disease (2010) (0)
- Extensive amyloid pathology in remote brain regions may predict hypometabolism in functionally connected brain regions with minor amyloid pathology: An Alzheimer's disease study (2012) (0)
- FDG-PET and metabolomics in PD-associated GBA variants (2018) (0)
- DIAGNOSTIC UTILITY OF FDG-PET IN DETECTING EARLY SIGNS OF NEURODEGENERATION IN ASYMPTOMATIC SUBJECTS WITH FAMILIAL FORMS OF AD (2017) (0)
- Prevalence and prognosis of Alzheimer’s disease at the mild cognitive impairment stage Neuroimaging (2015) (0)
- Contents Vol. 25, 2008 (2008) (0)
- Characterization of [F-18]FIBT, a highly selective and specific PET imaging agent for beta-amyloid plaques (2013) (0)
- Progression of metabolic decline and amyloid deposition in Alzheimer's disease (AD) and their regional relation to a functional connectivity network in healthy controls (2010) (0)
- PREVALENCE OF VASCULAR RISK FACTORS IN DIFFERENT STAGES OF PRODROMAL ALZHEIMER’S DISEASE AND ITS INFLUENCE ON COGNITIVE DECLINE (2016) (0)
- LRP1 is associated with global and regional amyloid load in Alzheimer's disease independent of APOE (2012) (0)
- Relative reduction of residual tumor improves outcome prediction of PET after effective chemotherapy for patients with advanced stage Hodgkin lymphoma (2012) (0)
- F-18-DOPA-PET predicts impulsive behavior under dopaminergic therapy in Parkinson patients (2017) (0)
- Synthesis, proteolytic stability, and in vitro evaluation of DOTA conjugated p160 peptide based radioconjugates: [177Lu]Lu-DOTA-p160. (2021) (0)
- F-18-PI-2620 3R Pick Tau PET Imaging in Frontotemporal Lobar Degeneration (FTLD) (2023) (0)
- RADIATION EXPOSURE FROM PATIENTS AFTER RADIOIODINE THERAPY FOR THYROID CANCER (2018) (0)
- Developments in oncological positron emission tomography/computed tomography assessment. (2015) (0)
- Contents Vol. 20, 2005 (2005) (0)
- First clinical experience with simultaneous whole body MR/PET imaging (2011) (0)
- Feasibility of voxel-based analysis of amyloid-burden in transgenic mice of Alzheimer's disease (2011) (0)
- Comparison of Structural and Metabolic Biomarkers for Brain Age Prediction using Machine Learning (2022) (0)
- Differences in dynamic functional connectivity across the alzheimer’s disease spectrum (2022) (0)
- MILD COGNITIVE IMPAIRMENT WITH SUSPECTED NON AD PATHOLOGY (SNAP): PREDICTION OF PROGRESSION TO DEMENTIA (2014) (0)
- THE AMYPAD-DX CONTROLLED TRIAL ON THE DIAGNOSTIC VALUE OF AMYLOID PET (2017) (0)
- Contents Vol. 23, 2007 (2007) (0)
- Association of MMSE and cortical glucose metabolism during resting and activation states in Alzheimer's disease before and after partial volume correction (2004) (0)
- Regional susceptibility of the default mode network is associated with clinical phenotypes of Alzheimer's disease (2019) (0)
- Chapter 12 – Brain Tumors (2018) (0)
- The speed limits of tau spreading: The contribution of regional amyloid and education (2021) (0)
- Bailey MIB 2015 (2015) (0)
- Assessment of F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy (2020) (0)
- Evolutionary Time and Human Memory (2017) (0)
- Amyloid cascade peptides in mild cognitive impairment with regard to Alzheimer's disease cerebral metabolic signature (2013) (0)
- Resistance to tau and amyloid pathology supports super‐aging (2020) (0)
- 18 F‐PI‐2620 tau‐PET in corticobasal syndrome (ActiGliA cohort): Neuroimaging: Other neurodegenerative disorders (2020) (0)
- Efficacy and safety of florbetaben for beta-amyloid brain positron emission tomography in Alzheimer's disease: Results from a global phase IIb trial (2011) (0)
- Comparison of two different transgenic mouse models of Alzheimer’s disease regarding their suitability for amyloid-β plaque microPET imaging with [11C]PIB (2008) (0)
- Evaluation of Visual Rating Scales for MRI Supported Diagnosis of Frontotemporal Lobar Degeneration (2012) (0)
- Alzheimer’s disease biomarker roadmap 2020: [18F]flortaucipir (2020) (0)
- Importance of magnetic resonance imaging and prostate‐specific membrane antigen PET‐CT in patients treated with salvage radical prostatectomy for radiorecurrent prostate cancer (2022) (0)
- Cerebellar Involvement in Visual On-Line Adaptation of Vertical Stroke Size: A PET Activation Study (2004) (0)
- In vivo Tau-PET indicates expansion of tau pathology within the default mode network in Alzheimer's disease (2015) (0)
- Subcortical tau‐accumulation predicts neuronal dysfunction in the cortex based on functional connectivity in 4R‐tauopathies (2022) (0)
- Multicenter phase II trial of florbetaben beta-amyloid PET imaging in Alzheimer's disease: Results in a close to clinically routine situation (2013) (0)
- Consistent metabolism across resting state FMRI networks but differing metabolism across states (2016) (0)
- Decoupling of regional neural activity and inter-regional functional connectivity in Alzheimer’s disease: a simultaneous PET/MR study (2021) (0)
- Differential contributions of Amyloid and Tau burden to Neurodegeneration in Alzheimer’s Disease: A multimodal in vivo PET study (2016) (0)
- Prefrontal hypometabolism is related to distant and not to local amyloid increases in functionally connected brain regions: A longitudinal PET/MR study in Alzheimer's disease (2013) (0)
- Modulation of brain network recruitment caused by STN DBS and L-DOPA in parkinsonian rats (2019) (0)
- Longitudinal trimodal imaging of midbrain-associated network degeneration in Parkinson’s disease (2022) (0)
- [Scintigraphic procedures in internal medicine--indications, limits, possibilities]. (2005) (0)
- Radioiodine therapy in differentiated thyroid cancer – a matter of controversy – PRO Radioiodine (2018) (0)
- Small animal 18F-FDG PET in vivo imaging of the penumbra in mice (2007) (0)
- LEVEL OF BRAIN RESERVE ASSOCIATED WITH SPATIAL EXTENT OF TAU-NEURODEGENERATION PATTERN IN ALZHEIMER’S DISEASE (2018) (0)
- Fully 4D image reconstruction of simultaneously acquired PET/MR data for [18F]FET (2012) (0)
- Erratum to: Impact of PET/CT image reconstruction methods and liver uptake normalization strategies on quantitative image analysis (2015) (0)
- Simultaneous Whole-Body PET / MR : Challenges and Opportunities (2011) (0)
- Differentiation of a Falcine Meningioma From Cerebral Venous Sinus Thrombosis Using DOTATATE PET. (2023) (0)
- The relationship of CSF biomarker of tau to in vivo tau pathology is mediated by amyloid levels in AD patients (2017) (0)
- Prevalence of abnormal Alzheimer’s disease biomarkers in patients with subjective cognitive decline: cross-sectional comparison of three European memory clinic samples (2019) (0)
- Altered limbic functional connectivity in individuals with subjective cognitive decline: Converging and diverging findings across Chinese and German cohorts. (2023) (0)
- Decoupling of inter-regional functional connectivity and regional neural activity in Alzheimer Disease (2019) (0)
- Prostate-Specific Membrane Antigen Uptake in a Peripheral Nerve and Respective Ganglia on 68Ga-Prostate-Specific Membrane Antigen-HBED-CC PET/CT. (2020) (0)
- A gatekeeper for amyloid status based on FDG‐PET and genetic risk in patients with mild cognitive impairment (2021) (0)
- Feasibility of O-(2-[18F]fluoroethyl)-L-tyrosine (FET) PET for treatment monitoring of brain metastases in lung cancer patients. (2019) (0)
- DIAGNOSTIC UTILITY OF FDG-PET IN DETECTING EARLY SIGNS OF NEURODEGENERATION IN ASYMPTOMATIC SUBJECTS WITH FAMILIAL FORMS OF AD (2017) (0)
- From molecules to system failure: translational frontiers of multimodal imaging in neurodegenerative diseases (2019) (0)
- Development of metabolically stabilized 11C-labeled 2-(4-aminophenyl)benzothiazols (BTAs) for imaging of amyloid plaques (2006) (0)
- 6 .Diagnostische Methoden (2018) (0)
- Imaging Amyloid in the Human Brain: A Promising Tool for Improved Early Diagnosis and Treatment Monitoring in Alzheimer`s Disease~!2009-10-21~!2010-01-20~!2010-05-06~! (2010) (0)
- IN VIVO TAUOPATHY MEASURED WITH [18F]-AV-1451 IS DIFFERENTIALLY RELATED TO CSF BIOMARKERS OF TAU IN ALZHEIMER’S DISEASE: THE INFLUENCE OF AMYLOID DEPOSITION (2017) (0)
- Simultaneous PET/MR imaging of brain metabolism and coherent intrinsic activity in the visual system (2013) (0)
- Influence of PET normalization methods on diagnosis of frontotemporal lobar degeneration and subtypes (2013) (0)
- Subcortical tau‐accumulation predicts neuronal dysfunction in the cortex based on functional connectivity in 4R‐tauopathies (2022) (0)
- Synthesis and evaluation of new compounds suitable for in vivo visualization of {beta}-amyloid plaques (2009) (0)
- Prefrontal hypometabolism in AD is related to longitudinal amyloid accumulation in remote brain regions (2015) (0)
- Anosognosia in Alzheimer’s disease associated with tau accumulation and hypometabolism in frontal areas (2020) (0)
- Correction: 18F-FIBT may expand PET for β-amyloid imaging in neurodegenerative diseases (2018) (0)
- Imbalanced metabolism between right and left temporoparietal junction predicts spatial bias in individuals with very early Alzheimer's disease (2009) (0)
- Unique regional patterns of amyloid burden predict progression to prodromal and clinical stages of Alzheimer’s disease (2021) (0)
- 1171P A phase II theranostic study with osimertinib in patients with EGFR-mutated non-small cell lung cancer (NSCLC) progressing on EGFR tyrosine kinase inhibitors (TKI) and undetectable EGFR T790M (THEROS) (2022) (0)
- The usefulness of amyloid-imaging in predicting the clinical outcome of patients with mild cognitive impairment (2011) (0)
- Subject Index Vol. 20, 2005 (2005) (0)
- Functional labelling of the human motor cortex by means of repetitive transcranial magnetic stimulation a pet activation study (2002) (0)
- Relationship between APOE-genotype and neurodegenerative brain pathologies, as assessed by neuroimaging procedures (2011) (0)
- P2-338 Assessment of cerebral hypometabolism and amyloid plaque load in semantic dementia and dementia of the Alzheimer type (2006) (0)
- Nuclear Imaging of Dementia (2016) (0)
- Concordance in interpretation of FDG PET after chemotherapy in advanced stage Hodgkin lymphoma (2015) (0)
- Cerebrospinal Fluid BACE 1 Activity and Brain Amyloid Load in Alzheimer ’ s Disease (2014) (0)
- JAMA Neurology Peer Reviewers in 2017. (2018) (0)
- TAU PATHOLOGY BURDEN ASSOCIATED WITH LEVEL OF COGNITIVE RESERVE IN ALZHEIMER’S DISEASE (2017) (0)
- AMYPAD-DPMS PRELIMINARY RESULTS: PARTICIPANTS’ BASELINE FEATURES (2019) (0)
- Alzheimer’s disease core biomarkers and prediction of dementia in MCI: The effect of age at onset (2015) (0)
- Survival analysis, the infinite Gaussian mixture model, FDG-PET and non-imaging data in the prediction of progression from mild cognitive impairment (2015) (0)
- Region-specific association between cerebral glucose uptake and cognitive performance in patients with frontotemporal dementia. (2002) (0)
- The use of amyloid‐PET in memory clinic patients: AMYPAD Diagnostic and Patient Management Study (2022) (0)
- A metabolic topology of cognitive ageing, Parkinson's disease and dementia (2012) (0)
- IC-P-031 Brain reserve capacity in frontotemporal dementia (2006) (0)
- LuISA – Lu-177-PSMA intelligent szintigraphy analysis (2019) (0)
- Imaging of the Geriatric Brain (2014) (0)
- HARMONIZATION OF SCD OPERATIONALIZATION ACROSS DIFFERENT MEMORY CLINIC SETTINGS: THE EURO-SCD STUDY (2018) (0)
- C O N T I N U I N G E D U C a T I O N Spect/ct* (2008) (0)
- TAU PATHOLOGY BURDEN ASSOCIATED WITH LEVEL OF COGNITIVE RESERVE IN ALZHEIMER’S DISEASE (2017) (0)
- Neuropsychological deficits and regional cerebral glucose metabolism (RCMRGLC) in Huntington's disease (2005) (0)
- P4-111 Brain reserve capacity in frontotemporal dementia (2006) (0)
- Longitudinal trimodal imaging of midbrain-associated network degeneration in Parkinson’s disease (2022) (0)
- Functional connectivity during deep brain stimulation in the subthalamic nucleus of hemiparkinson rats measured with FDG-PET (2016) (0)
- Amyloid-Plaque Imaging in Diagnosis of Dementia (2009) (0)
- Comparing sensitivity of imaging biomarkers to track ad progression (2015) (0)
- Interhemispheric Metabolic Imbalance Between Temporoparietal Junctions and Inferior Parietal Lobules Correlates with Spatial Attentional Bias in Individuals with Very Early Alzheimer's Disease (2009) (0)
- Prefrontal hypometabolism in Alzheimer’s disease is caused by longitudinal amyloid accumulation in remote, functionally connected brain regions (2013) (0)
- Overlapping and distinct neural metabolic patterns related to impulsivity and hypomania in Parkinson’s disease (2018) (0)
- Introducing a gatekeeping system for amyloid status assessment in mild cognitive impairment (2022) (0)
- Is Alzheimer's disease with early-onset different from late-onset?: A comparison using amyloid and glucose positron emission tomography (2012) (0)
- Contents Vol. 12, 2001 (2001) (0)
- Regional quantitative dynamics and interrelations between brain metabolism and amyloid deposition during a two-year follow-up in patients with mild Alzheimer's disease (2012) (0)
- Subject Index Vol. 25, 2008 (2008) (0)
- In vivo imaging of cerebral amyloid plaque load and glucose metabolism in semantic dementia and Alzheimer's disease (2006) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Alexander E. Drzezga?
Alexander E. Drzezga is affiliated with the following schools:
